Nice_老虎社区_美港股上老虎

wowk
2021-08-21

Nice

Why Geovax Labs Shares Are Soaring Today

Geovax Labs Inc (NASDAQ: GOVX) is trading significantly higher Friday after the company announced it

Why Geovax Labs Shares Are Soaring Today

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":836242936,"tweetId":"836242936","gmtCreate":1629503800225,"gmtModify":1631888774743,"author":{"id":4087727806211160,"idStr":"4087727806211160","authorId":4087727806211160,"authorIdStr":"4087727806211160","name":"wowk","avatar":"https://static.tigerbbs.com/be32c03d2d55b876b5000ca3a0fce22a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Nice</p></body></html>","htmlText":"<html><head></head><body><p>Nice</p></body></html>","text":"Nice","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/836242936","repostId":2161748478,"repostType":4,"repost":{"id":"2161748478","kind":"news","pubTimestamp":1629467214,"share":"https://ttm.financial/m/news/2161748478?lang=&edition=full","pubTime":"2021-08-20 21:46","market":"us","language":"en","title":"Why Geovax Labs Shares Are Soaring Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2161748478","media":"Benzinga","summary":"Geovax Labs Inc (NASDAQ: GOVX) is trading significantly higher Friday after the company announced it","content":"<p><b>Geovax Labs Inc</b> (NASDAQ: GOVX) is trading significantly&nbsp;higher Friday after&nbsp;the company announced it presented data from ongoing studies of its preventive vaccine against COVID-19&nbsp;at the European Society of Medicine General Assembly.</p>\n<p>Using its novel Modified Virus Ankara-Virus Like Particle (GV-MVA-VLP)&nbsp;platform, GeoVax has developed a design strategy for vaccines expected to induce broader immunity through inclusion of multiple structural and nonstructural proteins from the target pathogen.</p>\n<p>The GV-MVA-VLP&nbsp;platform is known to elicit a balanced humoral&nbsp;and cellular response against a range of immunogens, which could possibly make immune escape against emerging variants less likely.</p>\n<p>\"In our studies, we observed the induction of functional antibodies and T-cell responses that mediate protection from infection and pathogenesis,\" said&nbsp;<b>Mark&nbsp;Newman</b>, chief scientific officer of Geovax Labs.</p>\n<p>Geovax Labs is a U.S.-based clinical-stage biotechnology company&nbsp;engaged in developing immunotherapies and vaccines against cancers and infectious diseases.</p>\n<p><b>Price Action:</b> Geovax Labs has traded as high as $8.71 and as low as 25 cents over a 52-week period.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Geovax Labs Shares Are Soaring Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Geovax Labs Shares Are Soaring Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-20 21:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-geovax-labs-shares-soaring-134654323.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Geovax Labs Inc (NASDAQ: GOVX) is trading significantly higher Friday after the company announced it presented data from ongoing studies of its preventive vaccine against COVID-19 at the European ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-geovax-labs-shares-soaring-134654323.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOVX":"GeoVax Labs Inc"},"source_url":"https://finance.yahoo.com/news/why-geovax-labs-shares-soaring-134654323.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2161748478","content_text":"Geovax Labs Inc (NASDAQ: GOVX) is trading significantly higher Friday after the company announced it presented data from ongoing studies of its preventive vaccine against COVID-19 at the European Society of Medicine General Assembly.\nUsing its novel Modified Virus Ankara-Virus Like Particle (GV-MVA-VLP) platform, GeoVax has developed a design strategy for vaccines expected to induce broader immunity through inclusion of multiple structural and nonstructural proteins from the target pathogen.\nThe GV-MVA-VLP platform is known to elicit a balanced humoral and cellular response against a range of immunogens, which could possibly make immune escape against emerging variants less likely.\n\"In our studies, we observed the induction of functional antibodies and T-cell responses that mediate protection from infection and pathogenesis,\" said Mark Newman, chief scientific officer of Geovax Labs.\nGeovax Labs is a U.S.-based clinical-stage biotechnology company engaged in developing immunotherapies and vaccines against cancers and infectious diseases.\nPrice Action: Geovax Labs has traded as high as $8.71 and as low as 25 cents over a 52-week period.","news_type":1,"symbols_score_info":{"GOVX":0.9}},"isVote":1,"tweetType":1,"viewCount":383,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}